Dean H. Bergy, advisor to the chief financial officer at Stryker, has become a member of the RTI Biologics board of directors, according to an RTI Biologics news release.
Previously, Mr. Bergy served as vice president of finance and chief accounting officer, vice president of finance for the medical division and corporate controller at Stryker.
He will be up for re-election in 2012.
Read the RTI Biologics release on Dean Bergy.
Read other coverage on RTI Biotics.
-RTI Biologics Develops Reimbursement Hotline for Sports Medicine
-RTI Biologics Posts 11% Higher Revenues in Third Quarter, a Record
Previously, Mr. Bergy served as vice president of finance and chief accounting officer, vice president of finance for the medical division and corporate controller at Stryker.
He will be up for re-election in 2012.
Read the RTI Biologics release on Dean Bergy.
Read other coverage on RTI Biotics.
-RTI Biologics Develops Reimbursement Hotline for Sports Medicine
-RTI Biologics Posts 11% Higher Revenues in Third Quarter, a Record